1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. DBV Technologies
  6. News
  7. Summary
    DBV   FR0010417345

DBV TECHNOLOGIES

(DBV)
  Report
Real-time Euronext Paris  -  11:35 2022-08-09 am EDT
5.135 EUR   -2.93%
08/03Kepler Cheuvreux Upgrades DBV Technologies to Buy From Hold
MT
08/02European ADRs Move Lower in Tuesday Trading
MT
08/01DBV TECHNOLOGIES : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Plunge in Tuesday Trading

07/05/2022 | 11:14am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 0.00% 2.22 Delayed Quote.-40.80%
AVADEL PHARMACEUTICALS PLC 15.85% 7.31 Delayed Quote.-9.53%
BANCO SANTANDER, S.A. 0.08% 2.556 Delayed Quote.-13.08%
BARCLAYS PLC -0.08% 165.86 Delayed Quote.-11.30%
BIONTECH SE -7.14% 157.21 Delayed Quote.-39.02%
DBV TECHNOLOGIES -2.93% 5.135 Real-time Quote.67.87%
DEUTSCHE BANK AG -0.82% 8.727 Delayed Quote.-20.79%
ENI SPA 0.40% 11.492 Delayed Quote.-6.33%
GENFIT 1.74% 4.448 Real-time Quote.3.06%
GRIFOLS, S.A. 0.36% 14 Delayed Quote.-17.04%
LONDON BRENT OIL -0.33% 96.07 Delayed Quote.20.61%
MATERIALISE NV -2.76% 13.05 Delayed Quote.-45.33%
NUCANA PLC -1.89% 1.56 Delayed Quote.-34.45%
PRUDENTIAL PLC -1.33% 989.2 Delayed Quote.-22.39%
SHELL PLC 1.06% 2184.5 Delayed Quote.34.70%
VERONA PHARMA PLC 44.32% 10.03 Delayed Quote.49.26%
WPP PLC -2.30% 798 Delayed Quote.-28.72%
WTI -0.34% 90.251 Delayed Quote.16.88%
All news about DBV TECHNOLOGIES
08/03Kepler Cheuvreux Upgrades DBV Technologies to Buy From Hold
MT
08/02European ADRs Move Lower in Tuesday Trading
MT
08/01DBV TECHNOLOGIES : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
08/01DBV TECHNOLOGIES S.A. Management's Discussion and Analysis of Financial Condition and ..
AQ
08/01DBV Technologies Reports Second Quarter 2022 Financial Results
GL
08/01DBV Technologies Reports Second Quarter 2022 Financial Results
GL
08/01DBV Technologies S.A. Reports Earnings Results for the Second Quarter and Six Months En..
CI
08/01European ADRs Move Higher in Monday Trading
MT
08/01DBV TECHNOLOGIES : Half-year results
CO
07/27Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GL
More news
Analyst Recommendations on DBV TECHNOLOGIES
More recommendations
Financials
Sales 2022 7,16 M 7,32 M 7,32 M
Net income 2022 -90,9 M -93,0 M -93,0 M
Net cash 2022 212 M 217 M 217 M
P/E ratio 2022 -6,18x
Yield 2022 -
Capitalization 482 M 493 M 493 M
EV / Sales 2022 37,8x
EV / Sales 2023 31,8x
Nbr of Employees 87
Free-Float 91,6%
Chart DBV TECHNOLOGIES
Duration : Period :
DBV Technologies Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DBV TECHNOLOGIES
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 5,14 €
Average target price 5,75 €
Spread / Average Target 12,0%
EPS Revisions
Managers and Directors
Daniel Tassé Chief Executive Officer & Executive Director
Sébastien Robitaille Chief Financial Officer
Michel de Rosen Non-Executive Chairman
Pharis Mohideen Chief Medical Officer
Pascal Wotling Chief Technical Operations Officer
Sector and Competitors
1st jan.Capi. (M$)
DBV TECHNOLOGIES67.87%508
MERCK KGAA-18.02%82 690
KYOWA KIRIN CO. LTD.0.48%12 575
SK BIOPHARMACEUTICALS CO., LTD.-15.64%4 845
BETTA PHARMACEUTICALS CO., LTD.-33.82%3 305
YUHAN CORPORATION-5.48%3 082